NCT04247269 is a clinical trial of Enteral Tube Feeding in Enteral Feeding Intolerance, sponsored by Société des Produits Nestlé (SPN).

Who is sponsoring NCT04247269?

NCT04247269 is sponsored by Société des Produits Nestlé (SPN).

What drugs are being tested in NCT04247269?

Interventions in NCT04247269: Enteral Tube Feeding.

What condition does NCT04247269 study?

NCT04247269 studies Enteral Feeding Intolerance, Tube Feeding, Nutrition Disorder, Child.

Is NCT04247269 still recruiting?

NCT04247269 is currently withdrawn. Last updated 9 June 2022.

Last reviewed 2022-06-09 · How we verify

NCT04247269

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Review of Enteral Formulas in Children

Withdrawn Last updated 9 June 2022

What this trial tests

trial testing Enteral Tube Feeding in Enteral Feeding Intolerance. Withdrawn.

Timeline

21 August 2020

Primary endpoint
2 June 2022

2 June 2022

Quick facts

Lead sponsor	Société des Produits Nestlé (SPN)
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	21 August 2020
Primary completion	2 June 2022
Estimated completion	2 June 2022
Sites	1 location across United States

Drugs / interventions tested

Enteral Tube Feeding

Conditions studied

Enteral Feeding Intolerance — all drugs for Enteral Feeding Intolerance →
Tube Feeding — all drugs for Tube Feeding →
Nutrition Disorder, Child — all drugs for Nutrition Disorder, Child →

Sponsor

Société des Produits Nestlé (SPN) — full company profile →

Who can join

Adults 1 to 18, any sex, with Enteral Feeding Intolerance or Tube Feeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective review of nutrition enteral formula data documented in medical records.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Enteral Feeding Intolerance

Currently open trials in the same condition.

NCT07312890 — Bedside Observation by Clinical Ultrasound for Stomach Expansion · NA · recruiting
NCT07092423 — Effect of Semi-elemental Enteral Nutrition on Gastrointestinal Tolerance in Patients With Traumatic Brain Injury. · NA · recruiting

Other Société des Produits Nestlé (SPN) trials

Trials by the same sponsor.

NCT07312201 — Oral Nutritional Supplementation in Children With Growth Concerns · NA · not yet recruiting
NCT07378111 — Vegetarian Tube Feed Study · NA · not yet recruiting
NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
NCT07127198 — Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04247269 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Société des Produits Nestlé (SPN)
Last refreshed: 9 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04247269.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing